An FDA Advisory Panel Voted to Ease Restrictions on 6 Controversial Peptides—Here’s What That Means

BEAUTY by .

Industry experts weigh in on what happens next after the consequential meetings to determine the future of peptides like BPC-157 and Epitalon.

close

Hi there
Sign up

And receive awesome content
in your inbox!.

We don’t spam! Read our privacy policy
for more info.

Leave a Reply

Your email address will not be published.